Can the development of psoriatic arthritis be prevented in patients with psoriasis? [Можно ли предотвратить развитие псориатического артрита у...
Насонов Е. Л., Коротаева Т. В., Лила А. М., Кубанов А. А.
Научно-практическая ревматология
Т. 57, Вып. 3, С. 250-254
Опубликовано: 2019
Тип ресурса: Статья
DOI:10.14412/1995-4484-2019-250-254
Аннотация:
Psoriatic arthritis (PsA) is a chronic immunoinflammatory disease that, on the one hand, is considered as the most common comorbidity in psoriasis as part of systemic psoriatic disease, and, on the other, is classified as a clinical form of spondyloarthritis and lies at the interface of the basic problems of rheumatology and dermatology. The study of the evolution of psoriasis in relation to the development of PsA is a research priority area in rheumatology and dermatology, which is important for deciphering the nature of heterogeneity and the immunopathogenesis mechanisms of these diseases and for developing novel methods of personalized therapy at different stages of diseases. © 2019 Ima-Press Publishing House. All rights reserved.
Ключевые слова:
Biomarkers; Immunogenetics; Psoriasis; Psoriatic arthritis
Article; dermatology; immunopathogenesis; personalized medicine; psoriasis; psoriatic arthritis; research priority; rheumatology
Язык текста: Русский
ISSN: 1995-4492
Насонов Е. Л. Евгений Львович 1948-
Коротаева Т. В.
Лила А. М.
Кубанов А. А.
Nasonov E. L. Evgenij L`vovich 1948-
Korotaeva T. V.
Lila A. M.
Kubanov A. A.
Can the development of psoriatic arthritis be prevented in patients with psoriasis? [Можно ли предотвратить развитие псориатического артрита у пациентов с псориазом?]
Can the development of psoriatic arthritis be prevented in patients with psoriasis? [Можно ли предотвратить развитие псориатического артрита у...
Текст визуальный непосредственный
Научно-практическая ревматология
ИМА-Пресс
Т. 57, Вып. 3 С. 250-254
2019
Статья
Biomarkers Immunogenetics Psoriasis Psoriatic arthritis
Article dermatology immunopathogenesis personalized medicine psoriasis psoriatic arthritis research priority rheumatology
Psoriatic arthritis (PsA) is a chronic immunoinflammatory disease that, on the one hand, is considered as the most common comorbidity in psoriasis as part of systemic psoriatic disease, and, on the other, is classified as a clinical form of spondyloarthritis and lies at the interface of the basic problems of rheumatology and dermatology. The study of the evolution of psoriasis in relation to the development of PsA is a research priority area in rheumatology and dermatology, which is important for deciphering the nature of heterogeneity and the immunopathogenesis mechanisms of these diseases and for developing novel methods of personalized therapy at different stages of diseases. © 2019 Ima-Press Publishing House. All rights reserved.